Management of the Hospitalized Transplant Patient
Open Access
- 27 February 2015
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 15 (4) , 19
Abstract
Significant hyperglycemia is commonly observed immediately after solid organ and bone marrow transplant as well as with subsequent hospitalizations. Surgery and procedures are well known to cause pain and stress leading to secretion of cytokines and other hormones known to aggravate insulin action. Immunosuppression required for transplant and preexisting risk are also major factors. Glucose control improves outcomes for all hospitalized patients, including transplant patients, but is often more challenging to achieve because of frequent and sometimes unpredictable changes in immunosuppression doses, renal function, and nutrition. As a result, risk of hypoglycemia can be greater in this patient group when trying to achieve glucose control goals for hospitalized patients. Key to successful management of hyperglycemia is regular communication between the members of the care team as well as anticipating and rapidly implementing a new treatment paradigm in response to changes in immunosuppression, nutrition, renal function, or evidence of changing insulin resistance.Keywords
This publication has 81 references indexed in Scilit:
- A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world settingIndian Journal of Endocrinology and Metabolism, 2013
- Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal TransplantationJournal of the American Society of Nephrology, 2012
- Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney TransplantationJournal of the American Society of Nephrology, 2011
- Glycemic Control by A Glucose Management Service and Infection Rates After Liver TransplantationEndocrine Practice, 2011
- Intraoperative Hyperglycemia Augments Ischemia Reperfusion Injury in Renal Transplantation: A Prospective StudyJournal of Transplantation, 2011
- Relationship between Inpatient Hyperglycemia and Insulin Treatment after Kidney Transplantation and Future New Onset Diabetes MellitusClinical Journal of the American Society of Nephrology, 2010
- Posttransplant Hyperglycemia is Associated With Increased Risk of Liver Allograft RejectionTransplantation, 2010
- Hyperglycemia during the Immediate Period after Kidney TransplantationClinical Journal of the American Society of Nephrology, 2009
- Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant RecipientsJournal of the American Society of Nephrology, 2008
- Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient SurvivalClinical Journal of the American Society of Nephrology, 2008